Mode of action of clinically important antifungal drugs.
D000499:Allylamine / Q000031:analogs & derivatives / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002467:Cell Nucleus / Q000187:drug effects; D002473:Cell Wall / Q000187:drug effects; D003881:Dermatomycoses / Q000188:drug therapy; D004352:Drug Resistance, Microbial; D005437:Flucytosine / Q000494:pharmacology; D005658:Fungi / Q000187:drug effects* / Q000648:ultrastructure; D006118:Griseofulvin / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D008870:Microtubules / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects; D008958:Models, Molecular; D009181:Mycoses / Q000188:drug therapy; D009696:Nucleic Acids / Q000378:metabolism; D013261:Sterols / Q000096:biosynthesis; D013329:Structure-Activity Relationship; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors
D000935:Antifungal Agents; D007093:Imidazoles; D009696:Nucleic Acids; D013261:Sterols; D006118:Griseofulvin; D000499:Allylamine; C029178:naftifine; D005437:Flucytosine; D013940:Thymidylate Synthase